CClinicalTrials.gg
Not yet recruitingNCT07803263Updated Sep 3, 2026

Frequency of Metabolic Acidosis in the Pediatric Intensive Care Unit

An observational study in Metabolic Acidosis, Acid-Base Imbalance and Critical Illness in Children, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Month to 1 Year. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
1 Month to 1 Year
Sex
All
01

Study summary

Metabolic acidosis is one of the most common acid-base disturbances encountered in critically ill children and often reflects underlying disease severity. Despite its clinical importance, prospective epidemiological data regarding its frequency, underlying etiologies, and associated clinical outcomes among pediatric intensive care unit (PICU) admissions in Upper Egypt remain limited.

The primary objective of this prospective observational cohort study is to determine the frequency of metabolic acidosis among pediatric patients admitted to the Pediatric Intensive Care Unit at Assiut University Children Hospital. Secondary objectives include identifying the common etiologies and types of metabolic acidosis, as well as evaluating its relationship with clinical outcomes such as mortality, duration of PICU stay, need for mechanical ventilation, and requirement for vasoactive support.

A total of 140 eligible pediatric patients aged 1 month to 18 years admitted to the PICU will be enrolled. Eligible patients will undergo arterial blood gas (ABG) analysis and standard clinical and laboratory evaluations upon admission. Metabolic acidosis will be defined based on admission ABG criteria (serum/arterial bicarbonate \< 22 mmol/L and/or base deficit ≥ 5 mmol/L). Patients will be monitored throughout their hospital stay to assess clinical outcomes without interfering with routine medical management.

02

Conditions studied

  • Metabolic Acidosis
  • Acid-Base Imbalance
  • Critical Illness in Children

Browse trials for

Keywords

  • Pediatric Intensive Care Unit
  • PICU
  • Arterial Blood Gas
  • Acidemia
  • Base Deficit
  • Serum Bicarbonate
  • Pediatric Critical Care
  • Mortality
03

Who can participate

Ages eligible
1 Month to 1 Year
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Pediatric patients aged 1 month up to 18 years admitted to the Pediatric Intensive Care Unit (PICU) at Assiut University Children Hospital during the study period who undergo arterial blood gas (ABG) analysis upon admission.

Inclusion criteria

  • Pediatric patients aged 1 month up to 18 years.
  • Admission to the Pediatric Intensive Care Unit (PICU).
  • Arterial blood gas (ABG) analysis performed on admission.

Exclusion criteria

Exclusion Criteria:

  • Neonates (age \< 1 month).
  • Readmission during the same hospital admission.
  • Patients with incomplete clinical or laboratory data.
  • Patients discharged or transferred before complete initial clinical and laboratory assessment
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Groups and cohorts

  • PICU Cohort

    Critically ill pediatric patients aged 1 month up to 18 years admitted to the Pediatric Intensive Care Unit (PICU) who undergo arterial blood gas analysis upon admission. Patients will be evaluated for the presence of metabolic acidosis and followed during their PICU stay to assess clinical outcomes, duration of stay, and mortality.

05

What researchers measure

Primary outcomes

  1. Percentage of Participants With Metabolic Acidosis on Admission

    Metabolic acidosis is defined based on arterial blood gas (ABG) analysis performed at admission as a serum or arterial bicarbonate concentration less than 22 mmol/L and/or a base deficit greater than or equal to 5 mmol/L. The outcome is measured as the percentage of participants meeting these criteria.

    Time frame: Baseline

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07803263
Lead sponsor
Assiut University
Responsible party
George Yousry Adeeb Azer (Resident of Pediatrics, Assiut University) — Principal investigator
First posted
Sep 3, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 3, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion